Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding

NCT02998775 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment; Renal Impairment

Interventions

DRUG: Plasma Sampling

Sponsor

Eisai Inc.